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Approach and avoidance are two basic behavioral aptitudes of humans whose correct
balance is critical for successful adaptation to the environment. As the expression of
approach and avoidance tendencies may differ significantly between healthy individuals,
different psychobiological factors have been posited to account for such variability.
In this regard, two main issues are still open that refers to (i) the role played by
dopamine neurotransmission; and (ii) the possible influence of cognitive characteristics,
particularly executive functioning. The aim of the present paper was to highlight
the contribution of research on Parkinson’s disease (PD) to our understanding of
the above issues. In particular, we here reviewed PD literature to clarify whether
neurobiological and neuropsychological modifications due to PD are associated to
changes in approach-avoidance related personality features. Available data indicate
that PD patients may show and approach-avoidance imbalance as documented by
lower novelty-seeking and higher harm-avoidance behaviors, possibly suggesting a
relationship with neurobiological and neurocognitive PD-related changes. However, the
literature that directly investigated this issue is still sparse and much more work is needed
to better clarify it.
Keywords: approach-avoidance, dopamine systems, Parkinson’s disease, personality, motivation disorders,
cognitive functioning, executive abilities
Introduction
Actively seeking contact with rewarding stimuli and avoiding unpleasant conditions in the
environment are critical in the functional adaptation of humans to their life context. Indeed,
people learn early that in some conditions they have to maintain an approach attitude to pursue a
desired goal and in other conditions they have to inhibit the tendency to move toward an object
or a person to avoid negative outcomes. This implementation balance in approach-avoidance
operations should allow the formation of behavioral modules at the level of the disposition to act,
which represent the pre-conditions for obtaining correct knowledge of the world and one’s own
limits, successful access to resources and, at the same time, provide for one’s own safety.
Within a psychobiological framework it has been posited that the activity of two main
motivation systems modulates the approach-avoidance aptitude of an individual: the behavioral
activation system and the behavioral inhibition system (Reinforcement Sensitivity Theory;
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Gray, 1970; Pickering and Gray, 2001). The first system was
considered to mediate behavior related to gratifying conditions
or potential positive outcomes of a situation and to be
specifically sensitive to rewarding or non-punishing stimuli and
to promote active searching for potentially rewarding conditions.
By contrast, the behavioral inhibition system was considered
particularly sensitive to punishment and non-rewarding stimuli.
It modulated behavior by inhibiting appetitive responses and
increasing arousal in order to improve attention to salient
and relevant stimuli, e.g., potentially harmful stimuli, in the
environment. The predominant activity of one of the two
above systems was considered to lead to greater or even
exclusive expression of behavioral moduli related to approach
or, alternatively, to avoidance aptitudes, thus determining an
individual’s stable dispositional response mode to external
stimuli.
Recent findings deriving from both animal (mammals)
models and human studies suggest that the activity of the
above-mentioned motivational systems and, thus, the degree
to which approach and avoidance behaviors can be expressed
in an individual, depends on the variable effects of both
biological and psychosocial factors. In particular, results of
studies with mammals show that the approach-avoidance
aptitude may be modulated by the central activity of the
neuropeptides oxytocin (OT) and arginine vasopressin (AVP)
in target brain regions (Young, 2002); interaction with the
dopamine reward system was also suggested (Skuse and
Gallagher, 2009). Human data document that in healthy
subjects personality traits and some cognitive processes may
be related to the likelihood of adopting approach or avoidance
behavior (Rettew et al., 2006; Spielberg et al., 2011). Finally,
in persons suffering from psychopathological disorders, the
approach-avoidance related motivational systems may show
differential sensitivity to environmental stimulation (Muris
et al., 2001; Hirano et al., 2002; Mitchell and Nelson-Gray,
2006). In view of the above observations, interest has recently
been centered on individual differences in approach-avoidance
behavior and on the possible role played by the interaction
between the different psychobiological factors in moderating its
expression.
Aims of the Review
The purpose of this paper was to highlight findings deriving
from research in individuals with PD that might contribute
to clarifying the factors related to individual differences in
approach and avoidance aptitude. In particular, we here
reviewed PD literature to clarify whether neurobiological and
neuropsychological modifications due to PD are associated
to changes in approach-avoidance related personality features.
We focused on this issue for three main reasons: First, PD
clinical manifestations are primarily a consequence of dopamine
dysfunction in neural networks whose activity is considered
important for sustaining the activity of behavioral motivation
systems (Young, 2002; Calabresi et al., 2006; Laricchiuta et al.,
2014). Second, some data suggest that PD patients develop
personality characteristics and psychopathological disorders
associated with avoidance behavior (Meyer et al., 1999;
Muris et al., 2001). Third, PD patients frequently present
neuropsychological disorders involving cognitive functions that
are critical for sustaining goal-directed behavior (Halliday et al.,
2014). These three points will be discussed by focusing mainly
on the results of studies that suggested a potential relationship
between the modifications occurring during the course of PD
and the expression of various aspects of approach and avoidance
behavior.
Methods
The studies were searched using electronic database Medline and
PsychoInfo in a period including the first months of 2014. In both
databases the same following keywords were used: Approach-
avoidance; Dopamine systems; Parkinson’s disease; Personality;
Motivation Disorders; Cognitive functioning; Executive abilities.
The studies included in the review should investigate, in PD
patients, personality traits that could be related to approach-
avoidance aptitude and their relationship with neurobiological
and neuropsychological variables. A list of the studies that were
considered with a description of main characteristics and results
is reported in Table 1.
Neurobiological Mechanisms of
Approach-Avoidance Behavior and PD:
Evidence of an Overlap
Neurobiologic Correlates of Approach-Avoidance
Behavior: Evidence from Non-PD Studies
Enter et al. (2012) found that dopamine transporter (DAT1)
polymorphisms were related to different approach-avoidance
behaviors when healthy adults were assessed using a task
that had stimuli with emotional social valence (i.e., human
faces). In particular, these authors demonstrated that, compared
with DAT1 10-repeat homozygote carriers DAT1 9-repeat
carriers showed an increased effect of the presented stimuli
(happy and angry faces) in approach-avoidance responses.
This finding suggests that the motivational behavioral systems
of these subjects are more sensitive. The DAT is involved
in dopamine reuptake in the striatum and the DAT1 9-
repeat carriers have been reported to have lower levels of
DAT than individuals with 10-repeat alleles, which indicates
that these subjects have higher dopamine concentrations in
the striatum (Heinz et al., 2000). Furthermore, in a recent
functional magnetic resonance imaging (fRMI) study in healthy
young subjects, Simon et al. (2010) documented greater
ventral striatal and mesial orbito-frontal cortex activation
when individuals who showed a high expression of reward-
seeking behavior actually received rewards. By contrast, they
found less ventral striatal activation when subjects who were
more prone to inhibit appetitive behavior received a reward
(Simon et al., 2010). These findings provide evidence in
line with previous data from animals models that dopamine
neurotransmission in neural networks (including the striatal
structures) is critically involved in the modulation of motivation
behavior (For a review on animalmodels see, Hoebel et al., 2007).
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TABLE 1 | The table summarizes the results of main studies investigating approach-avoidance related functioning in individuals with Parkinson’s disease
(PD).
Studies Study design Sample size Personality Results referring
(case/controls) measures to the PD group
Menza et al. (1993) Cross-sectional 51 PD; 31 controls with
rheumatologic diseases
TPQ Reduced Novelty seeking
Menza et al. (1995) Cross-sectional 9 PD TPQ Significant correlation between 6-[18F]fluorodopa
uptake in the caudate nucleus and novelty seeking
Jacobs et al. (2001) Cross-sectional;
Case-control
122 PD; 122 HCs TPQ Increased harm avoidance
Kaasinen et al. (2001) Cross-sectional;
Case-control
61 PD (47 underwent PET
examination); 45 healthy
subjects
TCI; KSP Reduced novelty seeking; increased harm avoidance;
significant association between increased harm
avoidance and 6-[18F]fluorodopa uptake in the
caudate nucleus
Tomer and Aharon-Peretz
(2004)
Cross-sectional;
Case-control
40 PD; 17 HCs TPQ Reduced novelty seeking; increased harm avoidance
Kaasinen et al. (2004) Cross-sectional 28 PD TCI Negative correlation between novelty seeking score
and insular cortex D2 receptors availability
McNamara et al. (2008) Cross-sectional;
Case-control
44 PD; 17 controls with chronic
disease
TCI Increased harm avoidance; Inverse correlation between
verbal fluency and harm avoidance rates.
Bódi et al. (2009) Longitudinal;
Case-control
48 PD; 20 HCs TCI Reduced novelty seeking; novelty seeking improvement
after dopamine treatment
Volpato et al. (2009) Cross-sectional 25 PD BFAC Significant association between alternating verbal
fluency and openness to experience factor
Arabia et al. (2010); Bower
et al. (2010)
Longitudinal 6,822 persons without PD at
baseline; 156 developed PD at
follow-up
MMPI Significant association between anxiety symptoms and
the risk of PD
Koerts et al. (2013) Cross-sectional;
Case-control
43 PD; 25 HCs TCI Higher harm avoidance; Cognitive flexibility predicts
reward dependence
Damholdt et al. (2014) Cross-sectional 409 PD Neo-FFI Reduced extraversion rates associated with depression
HCs: Healthy control subjects; PET: Positron emission tomography; TPQ: Tridimensional Personality Questionnaire (Cloninger, 1987); TCI: Temperament and Character
Inventory (Cloninger et al., 1993); KSP: Karolinka Scales of Personality Questionnaire (Schalling et al., 1987); BFAC: Big Five Adjective Checklist (Caprara et al., 2002);
MMPI Minnesota Multiphasic Personality Inventory (Dahlstrom et al., 1972); Neo-FFI: Neo-Five Factor Inventory (Costa and McCrae, 1992).
In particular, based on findings suggesting that dopamine
activity would promote appetitive behavior (e.g., moving toward
external stimuli, reward seeking), whereas acetylcholine would
mainly enhance behavioral inhibition and aversive responses
(Mark et al., 1995; Avena et al., 2006), Hoebel et al.
(2007) proposed that dopamine interacts with acetylcholine
in the ventral striatum (i.e., in the nucleus accumbens) to
maintain a functional balance between approach and avoidance
tendencies.
Neurobiological Modifications in PD
PD is a well-known neurological disease that is primarily
characterized by dysregulation of the nigro-striatal, mesolimbic
and the mesocortical dopaminergic brain systems. (Owen,
2004; Dickson et al., 2009). More specifically, degeneration
of the dopamine cells in the midbrain leads to precocious
and severe dopamine depletion in the striatum, which first
involves the rostrodorsal extent of the head of the caudate
nucleus and, later, the ventral tegmental neurons that project
to more ventral parts of this structure and to prefrontal
and limbic regions (Yeterian and Pandya, 1991; Agid et al.,
1993; Costa et al., 2009). In fact, in addition to movement
disorders PD patients often display cognitive-behavioral deficits
(Robbins and Cools, 2014). Although the role of dopamine
brain transmission in causing cognitive-behavioral disorders
in PD has not yet been completely clarified, in the early
phase of the disease cognitive deficits are considered due to
an imbalance between phasic dopamine activity in the dorsal
striatum and tonic dopamine activity in the prefrontal cortex,
which leads to reduced efficiency of flexibility processes (i.e.,
updating and set-shifting) (Cools, 2006; Cools and D’Esposito,
2011). With disease progression and the parallel greater
involvement of dopamine transmission in the ventral striatum
and the dopamine projections to the other structures of
the mesolimbic system, reduced ability to decode and use
environmental stimulation (e.g., reinforcers) to adopt functional
behavior, and altered emotional processing and declarative
memory disorders are observed. The hypothesis was also
advanced that the disrupted equilibrium between the activity of
dopamine and acetylcholine, which occurs in the striatum, could
account for some of the cognitive-behavioral manifestations
of PD (Calabresi et al., 2006). As stated above, dopamine
projections to striatal structures are primarily affected in PD,
thus causing a decrease of dopamine activity and, likely, a
parallel increase of cholinergic tone. According to Calabresi
et al. (2006) the altered dopamine-acetylcholine equilibrium
could affect synaptic mechanisms of long-term potentiation
and depression and of synaptic depotentiation, in some way
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modifying frontalstriatal interconnections and causing learning
and executive disorders.
The above mentioned evidence suggests that PD may
precociously cause functional and structural changes in frontal-
striatal regions whose activity is supposed to be responsible
for the modulation of approach and avoidance responses in
animals as well as in humans. Thus, PD is an interesting
natural human model for investigating the psychobiological
mechanisms involved in learning and sustaining these behavioral
aptitudes.
Do the Personality and Psychopathological
Features of PD Indicate an
Approach-Avoidance Imbalance?
In the previous section we suggested that the neuropathological
processes of PD might affect the functioning of brain circuitries
involved in the mediation of approach and avoidance tendencies.
This leads to the key question of whether these two main
aspects of the behavioral motivational systems are impaired in
PD patients. Some clinical reports are in line with this idea. In
fact, a large proportion of PD patients suffer from depressive
disorders and apathy (Aarsland et al., 2011; Martínez-Horta
et al., 2013), which have been shown to be associated with
a significant decrease of appetitive and self-initiated behaviors
also in PD (Costa et al., 2006; Martínez-Horta et al., 2013;
Damholdt et al., 2014; Spielberg et al., 2014). Anxiety symptoms,
which are associated with avoidance behavior, particularly in the
context of social interactions (Wong and Moulds, 2011), are also
frequently described in these patients (Sagna et al., 2014). An
opposite behavioral pattern, characterized by excessive attraction
to rewarding stimuli, is observed in some PD individuals
who develop impulse control disorders especially in response
to the administration of dopamine therapy (Callesen et al.,
2013).
More direct evidence of an imbalance between the behavioral
activation and inhibition systems comes from research on the
personality functioning of PD patients. These data document that
personality traits such as novelty seeking, which mainly refers to
the propensity towards active exploration in response to novel
stimuli and the avoidance of frustration (Cloninger, 1987), are
expressed to a lesser extent in PD patients compared to controls
without neurologic diseases (Menza et al., 1993; Bódi et al., 2009;
for a review see Poletti and Bonuccelli, 2012). By contrast, the
personality trait of harm avoidance, which is characterized by the
inclination to adopt a passive avoidance behavior, was found to
be much more present in PD patients than in controls (Jacobs
et al., 2001; Tomer and Aharon-Peretz, 2004; McNamara et al.,
2008; Koerts et al., 2013). Other studies reported evidence of
reduced extraversion in PD patients (Damholdt et al., 2014),
which probably indicates their low aptitude for approach social
interactions (McCrae and Costa, 1997).
Personality Modifications May Predate Clinical
Manifestation of PD
It was also hypothesized that personality changes might
occur in a pre-clinical phase of PD. This hypothesis was
mainly grounded on the observation that the presence of a
personality with low novelty-seeking functioning, rigidity and
caution predates the onset of extrapyramidal symptoms (for
a review see Menza, 2000). Nevertheless, few longitudinal
studies have been conducted to investigate this hypothesis. In
this regard, some interesting data were reported by Bower
et al. (2010) and by Arabia et al. (2010) in a cohort study
in which more than 6,800 persons were followed for four
decades. The Minnesota Multiphasic Personality Inventory,
a validated psychometric test that investigates psychological
disorders (Dahlstrom et al., 1972), was used to assess personality.
The authors did not find a clear relationship between the
constructs of introversion and extroversion and the risk of
PD. However, results showed that an anxious personality,
as assessed by the psychoastenia scale, is associated with a
higher risk of developing PD with a hazard ratio of 1.63. This
finding is quite interesting for our discussion because there are
reports that anxiety symptoms are associated with avoidance
behavior in both human studies (Muris et al., 2001; Wong
and Moulds, 2011) and animal models (Toth and Neumann,
2013). Evidence that the neurobiochemical alterations of PD
occur years before clinical manifestation of the disease also
support the idea of a correlation with these personality changes.
Nevertheless, findings from studies that directly correlated the
personality changes and neurobiological modifications of PD are
still sparse.
Relationship between Personality Changes and
Neurobiological Modifications in PD
Findings Indicating a Positive Association
Bódi et al. (2009) documented a significant relationship
between dopamine stimulation and novelty seeking in drug-
naïve PD patients. In particular, they investigated the effect
of dopamine agonist administration on different personality
traits (i.e, novelty seeking, harm avoidance, reward dependence
and persistence) and on reward-learning using a feedback-
based task. Patients underwent two assessments in which
the examiners were blind to personality measures, test
results and medication conditions, the first without taking
any medication and the second after a 12-week period of
treatment with the D2 and D3 dopamine receptor agonists
pramipexole and ropinirole. At the first assessment PD
patients showed significantly lower novelty-seeking and
reward-learning scores than healthy controls. The second
assessment showed that dopamine intake significantly improved
PD patients’ novelty-seeking scores and reward-learning
performance so that they could no longer be distinguished
from healthy controls on these measures (Bódi et al.,
2009).
Tomer and Aharon-Peretz (2004) reported more complex
results. They showed that left-right side asymmetry of
dopamine-related pathology may differentially affect personality
functioning in PD patients. In fact, findings from this
study suggest that in these patients dopamine loss in the
left hemisphere is associated with reduced novelty- seeking
behavior while higher harm avoidance is related to dopamine
loss in the right hemisphere (Tomer and Aharon-Peretz, 2004).
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These findings are in line with those of a previous PET study
in PD patients in which Menza et al. (1995) demonstrated that
6-[18F]fluorodopa uptake in the caudate nucleus (of the left
hemisphere) correlated with novelty-seeking scores.
Above observations are congruent with previous evidence in
people without neurological disorders of the relevant role of
dopamine transmission in the striatum in modulating sensitivity
to reward- and novelty-seeking behavior (Leyton et al., 2002),
and would sustain the general hypothesys that novelty seeking is
strongly related to dopamine transmission (Cloninger, 2000; but
see Paris, 2005 for a critical review). Also interestingly, the above
findings are congruent with the hypothesis of brain hemispheric
asymmetry in mediating activation and inhibition behavioral
systems, with the left hemisphere more associated with approach
and the right hemisphere with avoidance (Spielberg et al.,
2013).
Studies Documenting a Non-Linear Association
between Personality Features and PD Related
Neurobiological Changes
Partially divergent results in respect to those above discussed
were reported in other studies with PD patients. Indeed,
Kaasinen et al. (2004) showed an inverse correlation between
novelty-seeking scores and dopamine receptor availability
in the insula, a brain region highly interconnected with the
striatum and suggested to be involved in different cognitive
and emotional processes in PD (Christopher et al., 2014).
The finding by Kaasinen et al. (2004) indicates that the
likelihood of PD patients expressing a higher novelty-seeking
aptitude corresponds with lower dopamine activity in this
structure. In another independent PET study Kaasinen
et al. (2001) also demonstrated that in unmedicated PD
patients novelty-seeking scores did not correlate with 6-
[18F]fluorodopa uptake in any of the target brain regions.
Instead, higher harm avoidance scores were positively
correlated with 6-[18F]fluorodopa uptake in the caudate
nucleus.
In summary, an imbalance between the activity of behavioral
activation and inhibition systems, characterized by lower
approach and higher avoidance tendencies, seems to be
present in PD patients (see Table 1 for a synthesis of
the results of the main studies). This is supported by
observations of their reduced novelty seeking, sensitivity to
reward and self-initiated behavior. However, results on the
potential role played by the neurobiological changes of PD
and this hypothesized imbalance are inconclusive. One limit
of most studies investigating this issue in PD patients is
the use of self-rating psychometric tools that require self-
judgment of one’s own characteristics. Further studies using
more objective, performance-based paradigms, which specifically
assess approach and avoidance behaviors, would be more
informative. For instance, to better understand the role of
dopamine neurotransmission in target brain regions on these
processes, a functional magnetic resonance protocol could be
used to investigate how dopamine administration/withdrawal
modulates neural activity in PD patients while they perform
approach-avoidance procedures. Future investigations should
also take into account several potentially confounding individual
clinical (e.g., disease duration, disease severity, side of onset,
pattern of movement disorders) and cognitive (e.g., presence
of dementia, mild cognitive impairment or attention disorders)
characteristics of the disease.
Are the Executive Disorders in PD
Potentially Related to Approach-Avoidance
Tendencies?
Results Evidencing an Association between
Approach-Avoidance Behavior and Executive
System in Individuals without PD
The interaction between approach and avoidance motivational
systems and executive functions appears to be critical for the
maintenance of goal pursuit and, thus, for the implementation
of adaptive behavior (for a review see Spielberg et al., 2008,
2013). This interaction has been observed in both behavioral
and neuroimaging investigations. Gray (2001) showed that the
induction of approach and withdrawal motivation differentially
affected subjects’ performance on verbal and spatial working
memory tasks. In a subsequent study Spielberg et al. (2011)
showed that trait motivation modulated dorsolateral prefrontal
cortex activity while healthy subjects were performing a selective
attention task (i.e., the Stroop color-word task). Specifically,
in a fMRI protocol, these authors explored changes in neural
activity as a function of subjects’ scores on questionnaires
investigating approach and avoidance temperament. Results
showed a significant positive correlation between approach
temperament scores and activation in the left superior and
middle frontal gyri. A positive association was also found
between avoidance scores and activation in the middle frontal
gyrus (bilaterally) and the left superior frontal gyrus (Spielberg
et al., 2011).
Similar results indicating an interaction at the level of the
prefrontal cortex between motivation and executive abilities
were previously reported by Pochon et al. (2002) and by
Taylor et al. (2004). Indeed, the prefrontal cortex has been
consistently found to be highly involved in the mediation of
several executive abilities (e.g., planning, working, multitasking,
prospective memory) and it is considered fundamental for the
correct organization of information and goal-directed behavior
(Miller and Cohen, 2001; Burgess et al., 2011; Yuan and Raz,
2014). A recently proposed integrated view accounts for the
interaction between approach-avoidance traits, state motivation
and executive skills in coherently pursuing internal goals
(Spielberg et al., 2013).
On the basis of the above observations it can be hypothesized
that the qualitative characteristics of executive functioning
influence the expression of individual approach and avoidance
tendencies. This hypothesis is corroborated by the clinical
manifestation of brain damage involving the prefrontal
cortices. These patients often present cognitive and behavioral
signs---such as a decrease in goal-directed behavior, apathy and
disinhibition---that could be related to an imbalance between
activation and inhibition systems.
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Results from Studies with PD Patients
We previously mentioned that PD patients present cognitive
disorders early in the disease course, which are primarily
related to dopamine dysfunction in the frontal-striatal circuitries
(Costa et al., 2014a), with convergent evidence documenting
their reduced ability to perform tasks sensitive to executive
functions (Dirnberger and Jahanshahi, 2013; Kudlicka et al.,
2013; Robbins and Cools, 2014). In particular, set-shifting
and updating efficiency appear to be reduced early, likely
affecting their ability to successfully maintain a goal- directed
behavior (Cools, 2006; Cools and D’Esposito, 2011). In fact, these
patients have difficulty in performing planning and multitasking
tests and in spontaneously retrieving the intention to perform
planned actions (Owen, 2004; Kliegel et al., 2011; Costa et al.,
2014b,c).
Based on above observations documenting both an
association between approach and avoidance motivational
systems and executive functions in non-PD individuals
and, in PD patients, a decreased efficiency of the executive
system, we could hypothesize, in the latters, the existence
of a relationship between executive dysfunctioning and
approach-avoidance imbalance. Some findings are in line
with these hypothesis (in Table 1 a synthesis of main results is
reported).
McNamara et al. (2008) reported, in 44 PD patients
without dementia, a significant inverse correlation between harm
avoidance rates, as assessed by means of the Temperament
and Character Inventory, and a measure of cognitive flexibility
and strategic access to information (i.e, verbal fluency). In
an other study, Volpato et al. (2009) administered to 25 PD
patients without dementia the Big Five Adjective Checklist to
examine different personality traits, and the Tower of London
test and Alternating Fluency test to investigate planning and set-
shifting, respectively. The authors found a significant correlation
between the personality factor of openness to experience and
PD patients’score on alternating fluencies, thus indicating a
significant relationship between this personality factor and
cognitive flexibility processes.
In a more recent study with 43 PD patients without
dementia, Koerts et al. (2013) investigated the relationship
between different components of executive functions (cognitive
flexibility, inhibition, working memory, planning and verbal
fluency) and various aspects of personality functioning (novelty
seeking, harm avoidance, persistence and reward dependence).
Neuropsychological tests and questionnaires (the Temperament
and Character Inventory) were administered to assess cognitive
and personality features, respectively. The authors found
that PD patients’ scores on cognitive flexibility measures
significantly predicted reward dependence rates (Koerts et al.,
2013).
In summary, taken together the above findings do not
allow us to make firm conclusions about the nature of
the relationship between executive functioning and approach-
avoidance imbalance in PD. Indeed, the reported associations
between some personality factors (i.e, reward dependance and
openness to experience) and cognitive flexibility is undoubtedly
interesting as neural activity in the frontal-striatal circuitries
has been demonstrated to be critical for both reward-related
behavior and cognitive flexibility (O’Doherty, 2004; Bódi et al.,
2009; Macdonald and Monchi, 2011). However, a better method
for investigating the relationship between executive functioning
and approach-avoidance aptitude in PD patients would be
to test the effect of cognitive training aimed at potentiating
executive abilities on approach-avoidance related behavior. The
observation of executive improvement combined with a change
in approach-avoidance behavior would be clear evidence of
a causal relationship. In this regard it should be noted that
some cognitive training has been proposed which significantly
enhances some components of executive functioning, e.g.,
cognitive flexibility, which, as we discussed here, may be
associated with approach-avoidance tendencies also in persons
with PD (Calleo et al., 2012; Costa et al., 2014b).
Conclusions
Currently, the main issues in the study of individual differences
in the expression of approach and avoidance behaviors are
(i) the role played by dopamine neurotransmission; and (ii)
the possible influence of cognitive characteristics, particularly
executive functioning. Regarding the first point, there is
some evidence that dopamine and its interaction with other
neuromodulators at the level of the mesocorticolimbic networks
affects these processes by modulating the learning of individual
response modalities (Skuse and Gallagher, 2009). However,
this evidence is mainly derived from results of studies that
used animal models; in fact, human data are inconclusive.
Regarding the second point, also in this case the results of
some studies suggest the existence of a potentially bidirectional
relationship between cognitive (executive) functioning and
approach-avoidance behavior. Extant findings are, however, still
sparse and not univocal.
Here we highlight the potentially relevant contribution
of research on PD in clarifying above issues. In fact, PD
is characterized early by dopamine loss in brain circuitries
including the frontal-striatal, mesolimbic and mesocortical
pathways, that are implicated in sustaining the functioning of
motivational behavioral systems and executive processes.
Some evidence seem to support the idea that PD may be
associated to an alteration of approach-avoidance behaviors,
wherein it documents that PD patients show reduced novelty
seeking and higher harm avoidance expression. However, the
literature that directly investigated the relationship between PD
patients’ neurobiological and neuropsychological modifications
and approach-avoidance related personality functioning gave
inconclusive results. Further research that overcomes the limits
of previous studies (e.g., low sample size, clinical heterogeneity,
heterogeneity of dopamine treatments, use of self-report
questionnaires) are needed to further explore these important
topics in PD.
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